CELECOX

Celecox Adverse Events Reported to the FDA Over Time

How are Celecox adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Celecox, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Celecox is flagged as the suspect drug causing the adverse event.

Most Common Celecox Adverse Events Reported to the FDA

What are the most common Celecox adverse events reported to the FDA?

Drug Eruption	57 (4.82%)
Pyrexia	40 (3.38%)
Rash	25 (2.12%)
Death	22 (1.86%)
Erythema Multiforme	18 (1.52%)
Cardiac Failure	17 (1.44%)
Loss Of Consciousness	17 (1.44%)
Pneumonia	17 (1.44%)
Toxic Skin Eruption	15 (1.27%)
Fall	14 (1.18%)
Interstitial Lung Disease	14 (1.18%)
	Show More
Hepatic Function Abnormal	13 (1.1%)
Rash Generalised	13 (1.1%)
Stevens-johnson Syndrome	13 (1.1%)
Platelet Count Decreased	12 (1.02%)
Gastric Ulcer Haemorrhage	11 (.93%)
Laryngeal Oedema	11 (.93%)
Lip Oedema	11 (.93%)
Altered State Of Consciousness	10 (.85%)
Angina Pectoris	10 (.85%)
Diarrhoea	10 (.85%)
Malaise	9 (.76%)
Vomiting	9 (.76%)
Blister	8 (.68%)
Dizziness	8 (.68%)
Gastric Cancer	8 (.68%)
Renal Impairment	8 (.68%)
Skin Laceration	8 (.68%)
Agranulocytosis	7 (.59%)
Drug Interaction	7 (.59%)
Liver Disorder	7 (.59%)
Lumbar Vertebral Fracture	7 (.59%)
Oropharyngeal Pain	7 (.59%)
Pharyngeal Erythema	7 (.59%)
Rash Maculo-papular	7 (.59%)
Systemic Lupus Erythematosus	7 (.59%)
Tongue Oedema	7 (.59%)
Anaemia	6 (.51%)
Anaphylactic Shock	6 (.51%)
Aortic Aneurysm	6 (.51%)
Arterial Thrombosis	6 (.51%)
Chest Pain	6 (.51%)
Deep Vein Thrombosis	6 (.51%)
Dyspnoea	6 (.51%)
Face Oedema	6 (.51%)
Oral Mucosal Eruption	6 (.51%)
Pain	6 (.51%)
Palpitations	6 (.51%)
Retinal Vein Occlusion	6 (.51%)
Subarachnoid Haemorrhage	6 (.51%)
Thromboangiitis Obliterans	6 (.51%)
Urinary Retention	6 (.51%)
Abdominal Pain Upper	5 (.42%)
Bone Marrow Failure	5 (.42%)
Chills	5 (.42%)
Convulsion	5 (.42%)
Enterocolitis	5 (.42%)
Erythema	5 (.42%)
Feeling Abnormal	5 (.42%)
Muscular Weakness	5 (.42%)
Oedema	5 (.42%)
Oedema Mouth	5 (.42%)
Oedema Peripheral	5 (.42%)
Pulmonary Embolism	5 (.42%)
Purpura	5 (.42%)
Somnolence	5 (.42%)
Acute Generalised Exanthematous Pus...	4 (.34%)
Alcoholism	4 (.34%)
Analgesic Asthma Syndrome	4 (.34%)
Anxiety	4 (.34%)
Aortic Dissection	4 (.34%)
Arrhythmia	4 (.34%)
Asthenia	4 (.34%)
Asthma	4 (.34%)
Atrioventricular Block Complete	4 (.34%)
Cerebral Infarction	4 (.34%)
Cheilitis	4 (.34%)
Circulatory Collapse	4 (.34%)
Confusional State	4 (.34%)
Cross Sensitivity Reaction	4 (.34%)
Delusion	4 (.34%)
Dermatitis Exfoliative	4 (.34%)
Duodenal Ulcer	4 (.34%)
Dyspepsia	4 (.34%)
Emphysema	4 (.34%)
Gait Disturbance	4 (.34%)
Haemorrhage Subcutaneous	4 (.34%)
Hallucination	4 (.34%)
Head Injury	4 (.34%)
Hyperhidrosis	4 (.34%)
Hypoalbuminaemia	4 (.34%)
Intestinal Obstruction	4 (.34%)
Mouth Haemorrhage	4 (.34%)
Organising Pneumonia	4 (.34%)
Pancytopenia	4 (.34%)
Skin Necrosis	4 (.34%)
Sudden Onset Of Sleep	4 (.34%)
Swelling Face	4 (.34%)
Thrombocytopenia	4 (.34%)
Tremor	4 (.34%)
Urticaria	4 (.34%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Celecox, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Celecox is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Celecox

What are the most common Celecox adverse events reported to the FDA?

Epidermal And Dermal Conditions	189 (15.99%)
Neurological	51 (4.31%)
Body Temperature Conditions	41 (3.47%)
Oral Soft Tissue Conditions	35 (2.96%)
Injuries	32 (2.71%)
Gastrointestinal Signs	29 (2.45%)
Infections - Pathogen Unspecified	27 (2.28%)
Cardiac Arrhythmias	26 (2.2%)
Fatal Outcomes	26 (2.2%)
Hepatic And Hepatobiliary	25 (2.12%)
Hematology Investigations	24 (2.03%)
	Show More
Lower Respiratory Tract Disorders	22 (1.86%)
Gastrointestinal Ulceration And Per...	20 (1.69%)
Heart Failures	20 (1.69%)
Upper Respiratory Tract Disorders	20 (1.69%)
Respiratory	19 (1.61%)
Coronary Artery	17 (1.44%)
Anemias Nonhemolytic And Marrow Dep...	15 (1.27%)
Embolism And Thrombosis	15 (1.27%)
Renal Disorders	14 (1.18%)
Gastrointestinal Inflammatory Condi...	13 (1.1%)
Gastrointestinal Neoplasms Malignan...	13 (1.1%)
Therapeutic And Nontherapeutic Effe...	13 (1.1%)
Urinary Tract Signs	13 (1.1%)
White Blood Cell	12 (1.02%)
Disturbances In Thinking	11 (.93%)
Muscle	11 (.93%)
Allergic Conditions	10 (.85%)
Aneurysms And Artery Dissections	10 (.85%)
Bronchial Disorders	10 (.85%)
Central Nervous System Vascular	10 (.85%)
Decreased And Nonspecific Blood Pre...	10 (.85%)
Gastrointestinal Motility And Defec...	10 (.85%)
Skin Vascular Abnormalities	10 (.85%)
Movement Disorders	9 (.76%)
Vascular Inflammations	9 (.76%)
Bone And Joint Injuries	8 (.68%)
Deliria	8 (.68%)
Tongue Conditions	8 (.68%)
Cardiac Disorder Signs	7 (.59%)
Connective Tissue Disorders	7 (.59%)
Enzyme	7 (.59%)
Retina, Choroid And Vitreous Hemorr...	7 (.59%)
Skin Appendage Conditions	7 (.59%)
Anxiety Disorders	6 (.51%)
Electrolyte And Fluid Balance Condi...	6 (.51%)
Hepatobiliary	6 (.51%)
Joint	6 (.51%)
Leukemias	6 (.51%)
Microbiology And Serology	6 (.51%)
Ocular Infections, Irritations And ...	6 (.51%)
Physical Examination Topics	6 (.51%)
Platelet	6 (.51%)
Angiedema And Urticaria	5 (.42%)
Appetite And General Nutritional	5 (.42%)
Bacterial Infectious	5 (.42%)
Gastrointestinal Conditions	5 (.42%)
Pulmonary Vascular	5 (.42%)
Seizures	5 (.42%)
Water, Electrolyte And Mineral	5 (.42%)
Gastrointestinal Stenosis And Obstr...	4 (.34%)
Mental Impairment	4 (.34%)
Musculoskeletal And Connective Tiss...	4 (.34%)
Nephropathies	4 (.34%)
Protein And Amino Acid Metabolism	4 (.34%)
Psychiatric	4 (.34%)
Sleep Disturbances	4 (.34%)
Vision	4 (.34%)
Bladder And Bladder Neck Disorders	3 (.25%)
Cardiac And Vascular Investigations	3 (.25%)
Cardiac Valve	3 (.25%)
Eating Disorders	3 (.25%)
Eye	3 (.25%)
Gastrointestinal Hemorrhages	3 (.25%)
Headaches	3 (.25%)
Metabolic, Nutritional And Blood Ga...	3 (.25%)
Miscellaneous And Site Unspecified ...	3 (.25%)
Mood Disorders	3 (.25%)
Neurological Disorders Of The Eye	3 (.25%)
Protein And Chemistry Analyses	3 (.25%)
Renal And Urinary Tract Investigati...	3 (.25%)
Therapeutic Procedures And Supporti...	3 (.25%)
Vascular	3 (.25%)
Viral Infectious	3 (.25%)
Bone Disorders	2 (.17%)
Hemolyses And Related Conditions	2 (.17%)
Immunology And Allergy	2 (.17%)
Injuries By Physical Agents	2 (.17%)
Lifestyle Issues	2 (.17%)
Lipid Analyses	2 (.17%)
Medication Errors	2 (.17%)
Ocular Structural Change, Deposit A...	2 (.17%)
Peritoneal And Retroperitoneal Cond...	2 (.17%)
Pleural	2 (.17%)
Renal And Urinary Tract Neoplasms M...	2 (.17%)
Respiratory And Mediastinal Neoplas...	2 (.17%)
Salivary Gland Conditions	2 (.17%)
Skin And Subcutaneous Tissue	2 (.17%)
Tissue	2 (.17%)
Vascular Hypertensive	2 (.17%)
Coagulopathies And Bleeding Diathes...	1 (.08%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Celecox, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Celecox is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.